Cargando…
Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144
PURPOSE: Interleukin 6 (IL-6), Oncostatin M (OSM), and downstream effector STAT3 are pro-tumorigenic agents in pancreatic ductal adenocarcinoma (PDAC). Glycoprotein 130 (gp130) is a compound of the IL-6 and OSM receptor complex that triggers STAT3 signaling. SC144 is a small molecule gp130 inhibitor...
Autores principales: | Pozios, Ioannis, Hering, Nina A., Guenzler, Emily, Arndt, Marco, Elezkurtaj, Sefer, Knösel, Thomas, Bruns, Christiane J., Margonis, Georgios A., Beyer, Katharina, Seeliger, Hendrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889481/ https://www.ncbi.nlm.nih.gov/pubmed/36495330 http://dx.doi.org/10.1007/s00432-022-04518-9 |
Ejemplares similares
-
Targeting Interleukin-6/Glycoprotein-130 Signaling by Raloxifene or SC144 Enhances Paclitaxel Efficacy in Pancreatic Cancer
por: Hering, Nina A., et al.
Publicado: (2023) -
Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling
por: Pozios, Ioannis, et al.
Publicado: (2020) -
Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma
por: Seeliger, Hendrik, et al.
Publicado: (2018) -
Blockage of Cholinergic Signaling via Muscarinic Acetylcholine Receptor 3 Inhibits Tumor Growth in Human Colorectal Adenocarcinoma
por: Hering, Nina A., et al.
Publicado: (2021) -
Impact of myopenia and myosteatosis on postoperative outcome and recurrence in Crohn’s disease
por: Pozios, Ioannis, et al.
Publicado: (2022)